NCT06933394: Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma
- State
- Under way
- Phase
- Phase 2
- People
- 92 planned
- Started
- 1 May 2025
- Primary completion
- 1 May 2031
- Arms
- Experiment group
- Results
- None posted
- 18 Apr 2025: Trial registered